Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis.

Despite the enormous efforts displayed globally in the fight against tuberculosis, the disease incidence has modified slightly, which has led to a renewed interest in immunotherapy. In general, successful immunotherapeutic candidates against tuberculosis are agents that can trigger strong, specific pro-inflammatory responses, especially of the T-helper (Th) 1 pattern. However, how these pro-inflammatory agents effectively kill the bacteria without eliciting immunopathology is not well understood. We reasoned that, in addition to the specific immune response elicited by immunotherapy, the evaluation of the overall pro-inflammatory responses should provide additional and valuable information that will be useful in avoiding immunopathology. We evaluated the overall IFN-γ and IL-17 pro-inflammatory responses among CD4(+), CD8(+) and γδ T cells in the lungs of mice that were infected with M. tuberculosis and treated with a DNA vaccine in an immunotherapeutic regimen. Our results demonstrate that mice that effectively combat the pathogen develop a strong, specific Th1 immune response against the therapeutic antigen and have reduced lung inflammation, present in parallel a fine-tuning in the total IFN-γ- and IL-17-mediated immunity in the lungs. This modulation of the total immune response involves reducing the Th17 cell population, augmenting CD8(+) T cells that produce IFN-γ and increasing the total γδ T cell frequency. These results stress the importance of a broad evaluation of not only the specific immune response at the time to evaluate new immune interventional strategies against tuberculosis but also non-conventional T cells, such as γδ T lymphocytes.
AuthorsCarlos R Zárate-Bladés, Rodrigo F Rodrigues, Patricia R M Souza, Wendy M Rios, Luana S Soares, Rogério S Rosada, Izaíra T Brandão, Ana Paula Masson, Elaine M Floriano, Simone G Ramos, Celio L Silva
JournalHuman vaccines & immunotherapeutics (Hum Vaccin Immunother) Vol. 9 Issue 5 Pg. 1093-103 (May 2013) ISSN: 2164-554X [Electronic] United States
PMID23324590 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-17
  • Receptors, Antigen, T-Cell, gamma-delta
  • Interferon-gamma
  • Animals
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Disease Models, Animal
  • Female
  • Genetic Therapy (methods)
  • Inflammation
  • Interferon-gamma (secretion)
  • Interleukin-17 (secretion)
  • Lung (immunology, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Receptors, Antigen, T-Cell, gamma-delta (immunology)
  • Tuberculosis (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: